-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
Poseida Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2021 to Q1 2024.
- Poseida Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $1.5M, a 11.8% decline year-over-year.
- Poseida Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $6.3M, a 20.3% decline from 2022.
- Poseida Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $7.9M, a 29.5% increase from 2021.
- Poseida Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $6.1M, a 27.1% increase from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)